Here we go again, messing with people’s immune systems and acting like we know what we are doing. The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression system and recombinant DNA technology. Flublok is approved for the prevention of […]

Continue reading about Caveat Emptor: FDA Approves New Seasonal Influenza Vaccine Made Using Novel Technology